A vs IMA · P/E 29, rev $1.88B vs rev $9.2M
Agilent Technologies Inc (A) versus ImageneBio, Inc. (IMA) — a side-by-side from cached financials, not a winner call.
Agilent Technologies Inc (A) is a diagnostics & research company listed on US.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Latest reported A revenue for 2026-07-31 was $1.88B. Net income was $362.0M. Revenue was up 2.3% from 2026-04-30 to 2026-07-31. A currently screens at market cap $33.70B and trailing P/E 29.2.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
A currently screens at market cap $33.70B and trailing P/E 29.2. IMA currently screens at market cap $64.7M.
Not investment advice. Open the A and IMA stock pages for the full models.
Not investment advice.